# G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients

> **NCT00499343** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 84 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Etoposide
- **DRUG:** G-CSF
- **DRUG:** GM-CSF
- **DRUG:** Isophosphamide
- **DRUG:** Rituximab
- **PROCEDURE:** Apheresis

## Key facts

- **NCT ID:** NCT00499343
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2013-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00499343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00499343, "G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00499343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*